A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria — The ELIMINATE project

IF 6 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Liver International Pub Date : 2024-10-01 DOI:10.1111/liv.16076
Lorenz Balcar, Michael Schwarz, Livia Dorn, Mathias Jachs, Lukas Hartl, Lukas Weseslindtner, Nikolaus Pfisterer, Barbara Hennlich, Annika Stückler, Robert Strassl, Astrid Voill-Glaninger, Wolfgang Hübl, Martin Willheim, Karin Köhrer, Sonja Jansen-Skoupy, Sabine Tomez, Walter Krugluger, Christian Madl, Lukas Burghart, Lukas Antonitsch, Gerhard Weidinger, Florian Riedl, Hermann Laferl, Julian Hind, Christoph Wenisch, Christian Sebesta, Julia Wachter-Welzl, Paul Watzl, Magdalena Neuhauser, David Chromy, Mattias Mandorfer, Daniela Schmid, Michael Gschwantler, Thomas Reiberger, Andreas Maieron, David J.M. Bauer, Caroline Schwarz
{"title":"A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria — The ELIMINATE project","authors":"Lorenz Balcar,&nbsp;Michael Schwarz,&nbsp;Livia Dorn,&nbsp;Mathias Jachs,&nbsp;Lukas Hartl,&nbsp;Lukas Weseslindtner,&nbsp;Nikolaus Pfisterer,&nbsp;Barbara Hennlich,&nbsp;Annika Stückler,&nbsp;Robert Strassl,&nbsp;Astrid Voill-Glaninger,&nbsp;Wolfgang Hübl,&nbsp;Martin Willheim,&nbsp;Karin Köhrer,&nbsp;Sonja Jansen-Skoupy,&nbsp;Sabine Tomez,&nbsp;Walter Krugluger,&nbsp;Christian Madl,&nbsp;Lukas Burghart,&nbsp;Lukas Antonitsch,&nbsp;Gerhard Weidinger,&nbsp;Florian Riedl,&nbsp;Hermann Laferl,&nbsp;Julian Hind,&nbsp;Christoph Wenisch,&nbsp;Christian Sebesta,&nbsp;Julia Wachter-Welzl,&nbsp;Paul Watzl,&nbsp;Magdalena Neuhauser,&nbsp;David Chromy,&nbsp;Mattias Mandorfer,&nbsp;Daniela Schmid,&nbsp;Michael Gschwantler,&nbsp;Thomas Reiberger,&nbsp;Andreas Maieron,&nbsp;David J.M. Bauer,&nbsp;Caroline Schwarz","doi":"10.1111/liv.16076","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Aims</h3>\n \n <p>Identification of people living with hepatitis C virus (HCV) via readily available laboratory records could be a key strategy for macro-elimination, aligning with the WHO elimination goal. Therefore, the ELIMINATE(ELIMINation of HCV in AusTria East) project aimed to systematically re-link people with a ‘last-positive’ HCV-RNA PCR record to care.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In 10 major liver centres in Eastern Austria, a systematic readout of ‘last-positive’ HCV-RNA PCR test records obtained between 2008 and 2020 were conducted and linked to available patient contact data. Between 2020 and 2023, individuals were contacted first by phone, then by letter, to inform them about the availability of effective direct-acting antiviral (DAA) treatment and invite them for pre-treatment evaluation.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The overall cohort of last-positive HCV+ individuals included 5695 subjects (62.5% males, mean age 57.3 ± 17.3 years); of note, 1931 (34%) of them had died and 759 (13%) individuals had no valid contact information. Of the remaining 3005 individuals, 1171 (40.0%) had already achieved sustained virological response (SVR) at the time of re-call. We successfully reached 617 (20.5%), of whom 417 (67.6%) attended their pre-treatment visit, and 397 (64.3%) commenced DAA-therapy. HCV cure has been confirmed in 326 individuals, corresponding to an SVR rate of 82.1%.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The ELIMINATE project identified 5695 people living with HCV who were ‘lost to care’ despite documented HCV viraemia. While invalid contact data were an evident barrier to HCV elimination, premature deaths among the cohort underscored the severity of untreated HCV. The implementation of a systematic HCV-RNA PCR recorded-based re-call workflow represents an effective strategy supporting the WHO goal of HCV elimination.</p>\n </section>\n </div>","PeriodicalId":18101,"journal":{"name":"Liver International","volume":"44 12","pages":"3151-3163"},"PeriodicalIF":6.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.16076","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liver International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/liv.16076","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims

Identification of people living with hepatitis C virus (HCV) via readily available laboratory records could be a key strategy for macro-elimination, aligning with the WHO elimination goal. Therefore, the ELIMINATE(ELIMINation of HCV in AusTria East) project aimed to systematically re-link people with a ‘last-positive’ HCV-RNA PCR record to care.

Methods

In 10 major liver centres in Eastern Austria, a systematic readout of ‘last-positive’ HCV-RNA PCR test records obtained between 2008 and 2020 were conducted and linked to available patient contact data. Between 2020 and 2023, individuals were contacted first by phone, then by letter, to inform them about the availability of effective direct-acting antiviral (DAA) treatment and invite them for pre-treatment evaluation.

Results

The overall cohort of last-positive HCV+ individuals included 5695 subjects (62.5% males, mean age 57.3 ± 17.3 years); of note, 1931 (34%) of them had died and 759 (13%) individuals had no valid contact information. Of the remaining 3005 individuals, 1171 (40.0%) had already achieved sustained virological response (SVR) at the time of re-call. We successfully reached 617 (20.5%), of whom 417 (67.6%) attended their pre-treatment visit, and 397 (64.3%) commenced DAA-therapy. HCV cure has been confirmed in 326 individuals, corresponding to an SVR rate of 82.1%.

Conclusion

The ELIMINATE project identified 5695 people living with HCV who were ‘lost to care’ despite documented HCV viraemia. While invalid contact data were an evident barrier to HCV elimination, premature deaths among the cohort underscored the severity of untreated HCV. The implementation of a systematic HCV-RNA PCR recorded-based re-call workflow represents an effective strategy supporting the WHO goal of HCV elimination.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在奥地利,基于 PCR 记录的系统性 HCV-RNA 阳性患者再呼唤可实现重新连接护理和消除 HCV - ELIMINATE 项目。
背景和目的:通过现成的实验室记录来识别丙型肝炎病毒(HCV)感染者,是宏观消除丙型肝炎病毒的关键策略,符合世界卫生组织的消除目标。因此,ELIMINATE(ELIMINation of HCV in AusTria East)项目旨在系统地将具有 HCV-RNA PCR "最后一次阳性 "记录的患者与治疗重新联系起来:在奥地利东部的 10 个主要肝病中心,对 2008 年至 2020 年间获得的 HCV-RNA PCR 检测 "最后一次阳性 "记录进行了系统性读取,并将其与现有的患者联系数据联系起来。在 2020 年至 2023 年期间,首先通过电话,然后通过信件与患者取得联系,告知他们可以接受有效的直接作用抗病毒(DAA)治疗,并邀请他们接受治疗前评估:最后一次HCV阳性患者队列中共有5695人(62.5%为男性,平均年龄(57.3 ± 17.3)岁),其中1931人(34%)已经死亡,759人(13%)没有有效的联系信息。在剩余的 3005 人中,有 1171 人(40.0%)在再次召集时已获得持续病毒学应答(SVR)。我们成功联系到了 617 人(20.5%),其中 417 人(67.6%)接受了治疗前访视,397 人(64.3%)开始接受 DAA 治疗。326人被证实HCV治愈,相当于82.1%的SVR率:ELIMINATE项目发现了5695名HCV感染者,尽管他们有HCV病毒血症的记录,但却 "失去了治疗"。虽然无效的联系数据是消除 HCV 的一个明显障碍,但人群中过早死亡的病例凸显了未经治疗的 HCV 的严重性。实施系统的基于 HCV-RNA PCR 记录的重新呼叫工作流程是支持世界卫生组织消除 HCV 目标的有效策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Liver International
Liver International 医学-胃肠肝病学
CiteScore
13.90
自引率
4.50%
发文量
348
审稿时长
2 months
期刊介绍: Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor.
期刊最新文献
Issue Information Featured Cover Additional Cover MASLD, At-Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity. 166Ho-RadioEmbolizaTiOn Using personalized prediCtive dosimetry in patients with Hepatocellular carcinoma: A prospective, single-centre study (RETOUCH).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1